Heliomycin

This classification denotes an antibiotic with the molecular formula C22H16O6, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7N3A092A5X, chemically known as 2h-benzo(cd)pyrene-2,6(1h)-dione, 3,5,7,10-tetrahydroxy-1,1,9-trimethyl- but more generally known as heliomycin, which bears U.S. National Institutes of Health Compound Identifier 5282060. The European Medicines Agency schedules Heliomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08013MIG. The term HELIOMYCIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). HELIOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O=C1C(C2C3C4C1C(O)CC(O)C4C(=O)C1C3C(C(O)C2)C(CC1O)C)(C)C.